Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion — immunopathological findings
Ex vivo perfusions of human decay accelerating factor-expressing transgenic (n = 3), and nontransgenic (n = 6) porcine livers with human blood revealed a higher degree of organ damage in nontransgenic pig livers. Transgenic livers were protected from immunohistologically detectable complement deposition, despite corresponding IgM and IgG deposits in both groups. Complement activation and consumption of C3 and C4 turned out to be lower in transgenic pig livers. In contrast to livers of normal landrace pigs, livers from genetically manipulated pigs showed no morphological alterations after perfusion.
Key wordsDecay accelerating factor Transgenic pig Ex vivo perfusion Immunohistology Complement
Unable to display preview. Download preview PDF.
- 2.Burdick JF, Fair JH (1994) Xenoperfusion: the pig liver as a bridge. Xeno 2: 3–5Google Scholar